| 1. De Clercq E.. (2005) New approaches toward anti-HIV chemotherapy., 48 (5): [PMID:15743172] [10.1021/jm040158k] |
| 2. Price DA, Armour D, de Groot M, Leishman D, Napier C, Perros M, Stammen BL, Wood A.. (2006) Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc., 16 (17): [PMID:16782336] [10.1016/j.bmcl.2006.06.012] |
| 3. Ernst J, Dahl R, Lum C, Sebo L, Urban J, Miller SG, Lundström J.. (2008) Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists., 18 (4): [PMID:18194864] [10.1016/j.bmcl.2007.12.058] |
| 4. Barber CG, Blakemore DC, Chiva JY, Eastwood RL, Middleton DS, Paradowski KA.. (2009) 1-Amido-1-phenyl-3-piperidinylbutanes--CCR5 antagonists for the treatment of HIV: part 2., 19 (5): [PMID:19185490] [10.1016/j.bmcl.2009.01.008] |
| 5. Barber CG, Blakemore DC, Chiva JY, Eastwood RL, Middleton DS, Paradowski KA.. (2009) 1-Amido-1-phenyl-3-piperidinylbutanes - CCR5 antagonists for the treatment of HIV. Part 1., 19 (4): [PMID:19171484] [10.1016/j.bmcl.2009.01.009] |
| 6. Zachariae U, Giordanetto F, Leach AG.. (2009) Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers., 52 (14): [PMID:19534531] [10.1021/jm900002x] |
| 7. Duan M, Aquino C, Dorsey GF, Ferris R, Kazmierski WM.. (2009) 4,4-Disubstituted cyclohexylamine based CCR5 chemokine receptor antagonists as anti-HIV-1 agents., 19 (17): [PMID:19664920] [10.1016/j.bmcl.2009.07.074] |
| 8. Lemoine RC, Petersen AC, Setti L, Baldinger T, Wanner J, Jekle A, Heilek G, deRosier A, Ji C, Rotstein DM.. (2010) Evaluation of a 3-amino-8-azabicyclo[3.2.1]octane replacement in the CCR5 antagonist maraviroc., 20 (5): [PMID:20137937] [10.1016/j.bmcl.2010.01.080] |
| 9. Rotstein DM, Melville CR, Padilla F, Cournoyer D, Lee EK, Lemoine R, Petersen AC, Setti LQ, Wanner J, Chen L, Filonova L, Loughhead DG, Manka J, Lin XF, Gleason S, Sankuratri S, Ji C, Derosier A, Dioszegi M, Heilek G, Jekle A, Berry P, Mau CI, Weller P.. (2010) Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonists., 20 (10): [PMID:20417098] [10.1016/j.bmcl.2010.03.095] |
| 10. Huet T, Kerbarh O, Schols D, Clayette P, Gauchet C, Dubreucq G, Vincent L, Bompais H, Mazinghien R, Querolle O, Salvador A, Lemoine J, Lucidi B, Balzarini J, Petitou M.. (2010) Long-lasting enfuvirtide carrier pentasaccharide conjugates with potent anti-human immunodeficiency virus type 1 activity., 54 (1): [PMID:19805567] [10.1128/aac.00827-09] |
| 11. Stupple PA, Batchelor DV, Corless M, Dorr PK, Ellis D, Fenwick DR, Galan SR, Jones RM, Mason HJ, Middleton DS, Perros M, Perruccio F, Platts MY, Pryde DC, Rodrigues D, Smith NN, Stephenson PT, Webster R, Westby M, Wood A.. (2011) An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)., 54 (1): [PMID:21128663] [10.1021/jm100978n] |
| 12. Tallant MD, Duan M, Freeman GA, Ferris RG, Edelstein MP, Kazmierski WM, Wheelan PJ.. (2011) Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1., 21 (5): [PMID:21292480] [10.1016/j.bmcl.2011.01.030] |
| 13. Unpublished dataset, |
| 14. Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W.. (2011) FDA-approved drug labeling for the study of drug-induced liver injury., 16 (15-16): [PMID:21624500] [10.1016/j.drudis.2011.05.007] |
| 15. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 16. Navratilova I, Besnard J, Hopkins AL.. (2011) Screening for GPCR Ligands Using Surface Plasmon Resonance., 2 (7): [PMID:21765967] [10.1021/ml2000017] |
| 17. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 18. PubChem BioAssay data set, |
| 19. La Regina G, Coluccia A, Brancale A, Piscitelli F, Famiglini V, Cosconati S, Maga G, Samuele A, Gonzalez E, Clotet B, Schols D, Esté JA, Novellino E, Silvestri R.. (2012) New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors., 55 (14): [PMID:22712652] [10.1021/jm300477h] |
| 20. Pease J, Horuk R.. (2012) Chemokine receptor antagonists., 55 (22): [PMID:22931505] [10.1021/jm300682j] |
| 21. Asaftei S, Huskens D, Schols D.. (2012) HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationship., 55 (23): [PMID:23157587] [10.1021/jm301337y] |
| 22. Wittwer MB, Zur AA, Khuri N, Kido Y, Kosaka A, Zhang X, Morrissey KM, Sali A, Huang Y, Giacomini KM.. (2013) Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling., 56 (3): [PMID:23241029] [10.1021/jm301302s] |
| 23. Skerlj R, Bridger G, Zhou Y, Bourque E, McEachern E, Metz M, Harwig C, Li TS, Yang W, Bogucki D, Zhu Y, Langille J, Veale D, Ba T, Bey M, Baird I, Kaller A, Krumpak M, Leitch D, Satori M, Vocadlo K, Guay D, Nan S, Yee H, Crawford J, Chen G, Wilson T, Carpenter B, Gauthier D, Macfarland R, Mosi R, Bodart V, Wong R, Fricker S, Schols D.. (2013) Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replication., 56 (20): [PMID:24090135] [10.1021/jm401101p] |
| 24. Hu S, Gu Q, Wang Z, Weng Z, Cai Y, Dong X, Hu Y, Liu T, Xie X.. (2014) Design, synthesis, and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitors., 71 [PMID:24316669] [10.1016/j.ejmech.2013.11.013] |
| 25. Asano S, Gavrilyuk J, Burton DR, Barbas CF.. (2014) Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc., 5 (2): [PMID:24563723] [10.1021/ml400370w] |
| 26. Yuan Y, Arnatt CK, El-Hage N, Dever SM, Jacob JC, Selley DE, Hauser KF, Zhang Y.. (2013) A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities., 4 (5): [PMID:23682308] [10.1039/c3md00080j] |
| 27. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
| 28. Hu S, Wang Z, Hou T, Ma X, Li J, Liu T, Xie X, Hu Y.. (2015) Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists., 23 (5): [PMID:25638498] [10.1016/j.bmc.2014.12.052] |
| 29. Mirams GR, Davies MR, Brough SJ, Bridgland-Taylor MH, Cui Y, Gavaghan DJ, Abi-Gerges N.. (2014) Prediction of Thorough QT study results using action potential simulations based on ion channel screens., 70 [PMID:25087753] [10.1016/j.vascn.2014.07.002] |
| 30. Cox BD, Prosser AR, Sun Y, Li Z, Lee S, Huang MB, Bond VC, Snyder JP, Krystal M, Wilson LJ, Liotta DC.. (2015) Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase., 6 (7): [PMID:26191361] [10.1021/acsmedchemlett.5b00036] |
| 31. WHO Anatomical Therapeutic Chemical Classification, |
| 32. British National Formulary (72nd edition), |
| 33. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.. (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development., 136 (1): [PMID:23956101] [10.1093/toxsci/kft176] |
| 34. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 35. Shah HR, Savjani JK.. (2018) Recent updates for designing CCR5 antagonists as anti-retroviral agents., 147 [PMID:29425816] [10.1016/j.ejmech.2018.01.085] |
| 36. Sun Y, Xu W, Fan N, Sun X, Ning X, Ma L, Liu J, Wang X.. (2017) Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase., 25 (3): [PMID:28082070] [10.1016/j.bmc.2016.12.035] |
| 37. Unpublished dataset, |
| 38. Pirali T, Serafini M, Cargnin S, Genazzani AA.. (2019) Applications of Deuterium in Medicinal Chemistry., 62 (11): [PMID:30640460] [10.1021/acs.jmedchem.8b01808] |
| 39. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 40. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 41. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 42. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 43. Cerny MA, Kalgutkar AS, Obach RS, Sharma R, Spracklin DK, Walker GS.. (2020) Effective Application of Metabolite Profiling in Drug Design and Discovery., 63 (12): [PMID:32097005] [10.1021/acs.jmedchem.9b01840] |
| 44. Wang C, Wang X, Wang H, Pu J, Li Q, Li J, Liu Y, Lu L, Jiang S.. (2021) A "Two-Birds-One-Stone" Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region., 64 (15.0): [PMID:34261320] [10.1021/acs.jmedchem.1c00781] |
| 45. Xie X, Zheng YG, Chen H, Li J, Luo RH, Chen L, Zheng CB, Zhang S, Peng P, Ma D, Yang LM, Zheng YT, Liu H, Wang J.. (2022) Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability., 65 (24.0): [PMID:36472561] [10.1021/acs.jmedchem.2c01383] |
| 46. Qi B, Fang Q, Liu S, Hou W, Li J, Huang Y, Shi J.. (2020) Advances of CCR5 antagonists: From small molecules to macromolecules., 208 [PMID:32947226] [10.1016/j.ejmech.2020.112819] |
| 47. Arimont M, Sun SL, Leurs R, Smit M, de Esch IJP, de Graaf C.. (2017) Structural Analysis of Chemokine Receptor-Ligand Interactions., 60 (12): [PMID:28165741] [10.1021/acs.jmedchem.6b01309] |
| 48. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
| 49. European Medicines Agency, |
